Mesothelioma & Asbestos

Have you been diagnosed with pancreatic, colorectal or lung cancer after taking the weight-loss medication Belviq or Belviq XR?

You May Be Entitled To Compensation. 

FDA Recall on BELVIQ

Belviq® (lorcaserin hydrochloride) is a weight loss drug manufactured by Japanese drug maker Eisai originally approved for use by the FDA in 2012. Upon initial approval the FDA required Eisai to conduct a multiyear clinical trial to evaluate the risk of cardiovascular problems associated with Belviq® use. Risks of cancer also became a concern when a prevalence of tumors was observed in laboratory animals exposed to Belviq®.

Clinical Trial Results

Data collected from a five–year, 12,000 patient study of Belviq’s® potential negative cardiovascular side effects where half of the patients were given Belviq® and the other half given a placebo was reviewed by the FDA in January 2020. Outside of any cardiovascular side effects, the data showed a slightly greater occurrence of cancer diagnoses in the Belviq® patient sample set than in the placebo set (7.7% in patients who took Belviq® vs. 7.1% of patients who took the placebo). While a range of cancers were found in the sample, four cancers were found to occur disproportionately more than others in the Belivq® patients:

  • Pancreatic Cancer
  • Colon Cancer
  • Rectal Cancer
  • Lung Cancer

Based upon the findings, the FDA requested Eisai to voluntarily withdraw Belviq® and Belviq® XR (lorcaserin) from the market which they did in February 2020. At its peak, there were 600,000 prescriptions filled per year in the U.S. with no warning of potential increased risk of cancer. If you or someone you know may have a claim against Eisai, fill out the contact form below

Our Team

Our Team

Ad Hoc Committee for babies born opioid-dependent now represented in Purdue bankruptcy proceedings

November 13, 2019

Source : https://finance.yahoo.com/news/opioid-justice-team-ad-hoc-010000742.html Attorneys representing an Ad Hoc Committee for Neo-Natal Abstinence Syndr...

Read Full Article

3M Earplugs Radio Interview

August 19, 2019

Recently, a 9.1 million dollar settlement was reached in litigation surrounding a defective earplug (3M Earplugs) that was touted to prevent hearing damage...

Read Full Article

3M Earplug Hearing Loss Lawsuit

May 16, 2019

MBC Firm along with Berniard Law Firm, File 3m Earplug Lawsuit on behalf of an Army veteran, stationed in New Orleans....

Read Full Article

Medical Device Liability

May 16, 2019

Centola quoted in press on Medical Device Liability....

Read Full Article

PANINI REDEMPTION CLASS ACTION LAWSUIT 

February 8, 2019

            Martzell, Bickford & Centola and Roche & Company, LLC filed a Class Action against Panini America, Inc. for unfulfilled rede...

Read Full Article

What If You Are Arrested While Visiting New Orleans?

January 28, 2019

So, you came to New Orleans to have fun. That’s not a bad idea, considering our city has a festival almost every week of the year. Did you know there are...

Read Full Article

© 2020 Martzell, Bickford & Centola. All Rights Reserved. | Sitemap | Developed By MediaSmack